Title:
抗ウイルスピラゾロピリジノン化合物
Document Type and Number:
Japanese Patent JP7417715
Kind Code:
B2
Abstract:
The invention provides compounds of Formula (I)as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections, particularly infections caused by herpesviruses.
Inventors:
Konst, Zeff
Lou, Yiping
Morrow, Robert Joseph
Rajapaksa, Naomi Samadara
Sharn-Nance, Galen
Tully, David Charles
Turner, Michael Robert
Young, Joseph Michael
Jao, Chian
Corky, Britton Kay.
Metbo, Samuel E.
Lou, Yiping
Morrow, Robert Joseph
Rajapaksa, Naomi Samadara
Sharn-Nance, Galen
Tully, David Charles
Turner, Michael Robert
Young, Joseph Michael
Jao, Chian
Corky, Britton Kay.
Metbo, Samuel E.
Application Number:
JP2022518809A
Publication Date:
January 18, 2024
Filing Date:
September 24, 2020
Export Citation:
Assignee:
Novartis Age
Gilead Sciences, Inc.
Gilead Sciences, Inc.
International Classes:
C07D471/04; A61K31/437; A61K31/444; A61P1/04; A61P3/10; A61P9/10; A61P19/02; A61P25/00; A61P25/28; A61P29/00; A61P31/12; A61P31/22; A61P37/02
Foreign References:
| CN107936016A | ||||
| CN108178757A | ||||
| WO2004083177A2 |
Attorney, Agent or Firm:
Shusaku Yamamoto
Natsuki Morishita
Natsuki Morishita